Research
Hormonal
Weight loss exceeding 15% via bariatric surgery can reverse type 2 diabetes and is superior to conservative treatment for reducing incidence in individuals with BMI > 35 kg/m².
If your BMI is over 35, discuss bariatric surgery with your doctor. For this group, surgery is not just weight loss; it can reverse diabetes and is more effective than standard conservative treatments due to hormonal changes.
GoodSupportsHIGH confidence
Los endocrinólogos clínicos hemos aprendido de la cirugía bariátrica que la pérdida de peso mayor a 15% no solo puede revertir la diabetes mellitus, sino que también es mejor que el tratamiento conservador en la reducción de la incidencia de la misma en personas con IMC mayor a 35 Kg/m².
Why this rating
Based on cited clinical studies (Swedish Obese Subjects) showing reversal and incidence reduction.
Source
La prevención de la diabetes tipo 2. Muchas aristas y el peso como cuestión central
Elvio Bueno · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · 2015
DOI 10.18004/rvspmi/2312-3893/2015.02(01)08-010
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Structured lifestyle interventions targeting a 5% body weight loss through diet and exercise reduce the incidence of type 2 diabetes by approximately 55% over five years, outperforming pharmacological interventions like metformin.Strong
- Phentermine-topiramate combination therapy reduces the incidence of type 2 diabetes by 70% in prediabetic patients, demonstrating the power of significant weight loss via pharmacological means.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →